Need I say more?

in Stock Analysis by

Walgreens (WAG) comments on Wal-Mart (WMT) “will put them out of business strategy” on the company conference call:

  • For the 291 drugs that Wal-Mart will sell for $4, the average co-pay at Walgreens is $5.30 and for Medicare Part D patients it’s only $3.18.
  • Wal-Mart’s program covers less than 300 generic medications while Walgreens pharmacies’ stock has about 1800 different generics.
  • Over the years, WAG’s convenience, locations, and services have proven to be bigger factors for its patients than a few dollars in price difference – the point I argued in this article

    Need I say more?

  • Tags:

    Vitaliy N. Katsenelson, CFA, is Chief Investment Officer at Investment Management Associates in Denver, Colo. He is the author of Active Value Investing (Wiley) and The Little Book of Sideways Markets (Wiley). His books were translated into eight languages. Forbes Magazine called him "The new Benjamin Graham".

    Leave a Reply

    Latest from Stock Analysis

    Apple vs Coke

    Great Stock = Great Company + Great Valuation (Apple vs Coke) Valuation
    Go to Top

    DON`T MISS OUT!

    Get the latest investment articles in your inbox every week

    "Vitaliy Katsenelson is the new Benjamin Graham."

    - Forbes

    Tired of generic investment advice?

    CUT THROUGH THE BS - JOIN 15,000 READERS

    "Vitaliy Katsenelson is the new Benjamin Graham."

    - Forbes

    JOIN TO OUR NEWSLETTER

    Tired of generic investment advice?

    Sign Up for Articles

    Join tens of thousands of readers